首页|噻托溴铵联合沙美特罗替卡松治疗对慢性阻塞性肺疾病急性加重期患者的效果及安全性分析

噻托溴铵联合沙美特罗替卡松治疗对慢性阻塞性肺疾病急性加重期患者的效果及安全性分析

扫码查看
目的 分析噻托溴铵联合沙美特罗替卡治疗慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease,COPD)急性加重期患者的效果及其对安全性的影响.方法 选取2020年7月—2023年2月菏泽市立医院收治的92例COPD急性加重期患者为研究对象,经随机数表法分为对照组和观察组,各46例.对照组单纯吸入噻托溴铵治疗,观察组结合沙美特罗替卡松、噻托溴铵治疗.对比两组治疗效果、炎症指标、肺功能及安全性.结果 对照组治疗后总有效率低于观察组,差异有统计学意义(χ2=4.039,P<0.05).观察组各炎症因子水平均低于对照组,差异有统计学意义(t=5.436、2.393、3.569、17.803,P均<0.05);观察组肺部功能优于对照组,差异有统计学意义(t=3.630、6.838,P均<0.05);对照组不良反应总发生率(13.04%)高于观察组(2.17%),差异有统计学意义(χ2=3.866,P<0.05).结论 针对COPD急性加重期患者,采取噻托溴铵联合沙美特罗替卡松治疗治疗效果更加显著,且安全性更高.
Efficacy and Safety of Tiotropium Bromide Combined with Salmeterotica in the Treatment of Patients with Acute Exacerbation of Chronic Obstruc-tive Pulmonary Disease
Objective To analyze the efficacy and safety of tiotropium bromide combined with salmeterotica in the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease(COPD).Methods A total of 92 patients with acute exacerbation of COPD admitted to Heze Municipal Hospital from July 2020 to February 2023 were selected as the study objects,and they were randomly divided into control group and observation group by random number table method with 46 cases each.The control group was simply inhaled tiotropium bromide,and the observa-tion group was treated with salmeterotica and tiotropium bromide.The therapeutic effect,inflammatory index,lung function and safety of the two groups were compared.Results The total effective rate of the control group after treat-ment was lower than that of the observation group,and the difference was statistically significant(χ2=4.039,P<0.05).The levels of various inflammatory factors in the observation group were lower than those in the control group,and the differences were statistically significant(t=5.436,2.393,3.569,17.803,all P<0.05).The lung functions of observation group were better than thsoe of control group,and the differences were statistically significant(t=3.630,6.838,both P<0.05).The total incidence of adverse reaction in control group(13.04%)was higher than that in observation group(2.17%),and the difference was statistically significant(χ2=3.866,P<0.05).Conclusion For patients with acute exacer-bation of COPD,tiotropium bromide combined with salmeterotica has a more significant therapeutic effect and higher safety,which is worthy of clinical promotion.

Chronic obstructive pulmonary diseaseTiotropium bromideSalmeteroticaTherapeutic effect

任师磊

展开 >

菏泽市立医院呼吸与危重症医学科,山东菏泽 274000

慢性阻塞性肺疾病 噻托溴铵 沙美特罗替卡松 治疗效果 安全性

2024

系统医学

系统医学

ISSN:
年,卷(期):2024.9(9)